These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33341894)

  • 1. Potential benefits of dietary seaweeds as protection against COVID-19.
    Tamama K
    Nutr Rev; 2021 Jun; 79(7):814-823. PubMed ID: 33341894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of Marine Seaweeds as a Promising Defense Against COVID-19: a Mini-review.
    Gunathilaka MDTL
    Mar Biotechnol (NY); 2023 Jun; 25(3):415-427. PubMed ID: 37243809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Active Peptides of Marine Origin with ACE Inhibitory Activities: Potential Role as Anti-Hypertensive Drugs and in Prevention of SARS-CoV-2 Infection.
    Festa M; Sansone C; Brunet C; Crocetta F; Di Paola L; Lombardo M; Bruno A; Noonan DM; Albini A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
    Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
    J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of SARS-CoV-2 and Other Coronavirus With ACE (Angiotensin-Converting Enzyme)-2 as Their Main Receptor: Therapeutic Implications.
    Davidson AM; Wysocki J; Batlle D
    Hypertension; 2020 Nov; 76(5):1339-1349. PubMed ID: 32851855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of seaweed intake on health.
    Murai U; Yamagishi K; Kishida R; Iso H
    Eur J Clin Nutr; 2021 Jun; 75(6):877-889. PubMed ID: 32908248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms.
    Xu B; Li G; Guo J; Ikezoe T; Kasirajan K; Zhao S; Dalman RL
    J Vasc Surg; 2021 Nov; 74(5):1740-1751. PubMed ID: 33600934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2.
    Muchtaridi M; Fauzi M; Khairul Ikram NK; Mohd Gazzali A; Wahab HA
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32882868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
    Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED
    Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2).
    Zemlin AE; Wiese OJ
    Ann Clin Biochem; 2020 Sep; 57(5):339-350. PubMed ID: 32369402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
    Albini A; Di Guardo G; Noonan DM; Lombardo M
    Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
    Danser AHJ; Epstein M; Batlle D
    Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
    Joseph S; Nair B; Nath LR
    Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019.
    Zheng H; Cao JJ
    Am J Pathol; 2020 Oct; 190(10):2013-2017. PubMed ID: 32735889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.